Beacon Pointe Advisors, LLC
Position in AVXL — Anavex Life Sciences Corp.
CIK 1744317
NEWPORT BEACH, CA
Position in AVXL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$70,610
-$11,270 QoQ
Shares Held
23,000
0.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Beacon Pointe Advisors, LLC holds $39,716,074 across 25 Biotechnology names. AVXL ranks #19 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,460 | $15,035,574 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,894 | $7,990,386 | |
| 3 | INCY |
Incyte Corp
|
73,301 | $6,899,090 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
643,734 | $2,761,618 | |
| 5 | SMMT |
Summit Therapeutics Inc.
|
94,394 | $1,789,710 | |
| 6 | BNTX |
BioNTech SE
|
16,673 | $1,481,896 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
10,507 | $679,067 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
12,085 | $574,883 |
All Filings in AVXL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $70,610 | 23,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $81,880 | 23,000 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $204,700 | 23,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $212,060 | 23,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $197,340 | 23,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $247,020 | 23,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $130,640 | 23,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $97,060 | 23,000 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $91,620 | 18,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $167,580 | 18,000 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $119,373 | 18,225 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $146,340 | 18,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $154,260 | 18,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $166,680 | 18,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $185,760 | 18,000 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $180,180 | 18,000 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $221,580 | 18,000 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $316,021 | 18,225 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $327,138 | 18,225 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $416,623 | 18,225 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $272,463 | 18,225 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $98,415 | 18,225 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||